cagrilintide trial Efficacy and safety of co-administered once-weekly 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 cagrilintide

This product is intended for its marketed purpose and should be used only in accordance with applicable laws and regulations

Diluent: The liquid you'll use for reconstitution

When B12 is deficient, a buildup of methylmalonic acid occurs, which is toxic to the nervous system and contributes to neuropathy

When paired with a healthier diet and a consistent diet and exercise program, semaglutide therapy can help people lose stubborn pounds while promoting better blood sugar control and cardiovascular health

Improved Blood Sugar Control: These peptides help regulate blood glucose levels, making them beneficial for individuals with type 2 diabetes or insulin resistance

BPC-157 assists in stabilizing the brain-gut axis which controls how the brain, gut, microbiome and immune system interact